Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This study is a multi-center, randomized, triple-blind, placebo-controlled parallel-group trial, in which each participant is offered an N-of-1 trial. The purpose of this study is to assess the efficacy and safety of melatonin (3 mg or 6 mg) compared with placebo for initial insomnia in children with attention-deficit disorder.
Epistemonikos ID: a459a0b9fdbe3b7bbc952e66881f8f89f7b389fb
First added on: May 12, 2024